| NCT ID | NCT04196712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Essen |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 55,000 participants |
| Start Date | 2019-09-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 55,000 participants in total. It began in 2019-09-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The ECAD registry is a registry of patients undergoing coronary angiography at the West German Heart and Vascular Center. The registry anticipates to determine predictors of patient outcome after coronary angiography.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing invasive coronary angiography at the West German Heart and Vascular Center Exclusion Criteria: * None
Contact & Investigator
Tienush Rassaf, MD
PRINCIPAL INVESTIGATOR
University Hospital Essen, Deparment of Cardiology and Vascular Medicine
Frequently Asked Questions
Who can join the NCT04196712 clinical trial?
This trial is open to participants of all sexes, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04196712 currently recruiting?
Yes, NCT04196712 is actively recruiting participants. Contact the research team at amir-abbas.mahabadi@uk-essen.de for enrollment information.
Where is the NCT04196712 trial being conducted?
This trial is being conducted at Essen, Germany.
Who is sponsoring the NCT04196712 clinical trial?
NCT04196712 is sponsored by University Hospital, Essen. The principal investigator is Tienush Rassaf, MD at University Hospital Essen, Deparment of Cardiology and Vascular Medicine. The trial plans to enroll 55,000 participants.